Linking lipids, Alzheimer's and LXRs?
Nuclear Receptor Signaling · 2004
DOI: 10.1621/nrs.02001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Receptor Signaling, 2004. Verfasst von Nilay V Patel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gonda Diabetes Center, City of Hope National Medical Center, Duarte, CA 91010, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Deposition of the β-amyloid (Aβ) peptide is thought to underlie development of Alzheimer's disease (AD). This pathological linkage has spurred considerable interest in therapeutic strategies to reduce Aβ production. It is becoming increasingly clear that altered cholesterol homeostasis can modulate Aβ production and/or accumulation. In this review, we discuss the molecular pathology of AD, the cholesterol connection and recent data suggesting that the oxysterol receptor, liver X receptor LXR (NR1H2 and NR1H3), may modulate these events.
Autor:innen und Institutionen
- Gonda Diabetes Center, City of Hope National Medical Center, Duarte, CA 91010, USA.
Zitieren
APA
Patel, N. V., & Forman, B. M. (2004). Linking lipids, Alzheimer's and LXRs?. Nuclear Receptor Signaling. https://doi.org/10.1621/nrs.02001
Vancouver
Patel NV, Forman BM. Linking lipids, Alzheimer's and LXRs?. Nuclear Receptor Signaling. 2004. doi:10.1621/nrs.02001
BibTeX
@article{Patel2004,
author = {Patel, Nilay V and Forman, Barry Marc},
title = {Linking lipids, Alzheimer's and LXRs?},
journal = {Nuclear Receptor Signaling},
year = {2004},
doi = {10.1621/nrs.02001}
}
EUVIMED